title: Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
authors.affiliation: Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.|Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Deenen
authors.affiliation: Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands.
authors.forename: D
authors.initials: D
authors.lastname: Meulendijks
mesh_terms: D003110:Colonic Neoplasms; D015179:Colorectal Neoplasms; D054067:Dihydropyrimidine Dehydrogenase Deficiency; D042943:Dihydrouracil Dehydrogenase (NADP); D006801:Humans
chemical_list: D042943:Dihydrouracil Dehydrogenase (NADP)